Janux Therapeutics, Inc. (JANX) — DEFA14A Filings
All DEFA14A filings from Janux Therapeutics, Inc.. Browse 1 DEFA14A reports with AI-powered summaries and risk analysis.
DEFA14A Filings (1)
-
Janux Therapeutics Files Proxy Supplement
— Jun 17, 2024 Risk: low
Janux Therapeutics, Inc. filed a Definitive Additional Materials proxy statement on June 17, 2024. This filing supplements previous proxy materials and concerns
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX